ICCC vs RF
ImmuCell Corporation (ICCC) versus RF (RF) — a side-by-side from cached financials, not a winner call.
ImmuCell Corporation (ICCC) is a biotechnology company listed on US.
RF (RF) common stock.
Latest reported ICCC revenue for 2024-12-31 was $26.5M. Net income was -$2.2M. Revenue was up 51.6% from 2023-12-31 to 2024-12-31. ICCC currently screens at market cap $58.9M.
RF does not have a complete income-statement cache yet.
ICCC currently screens at market cap $58.9M. RF currently screens at market cap $0.
Not investment advice. Open the ICCC and RF stock pages for the full models.
Not investment advice.